Ofloxacin targeting to lungs by way of microspheres

International Journal of Pharmaceutics

Volumn 380, Issue 1-2, 2009, Pages 127-132

  Harsha, Sree ^a   R, Chandramouli ^b   Rani, Shobha ^c  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b SASTRA UNIVERSITY   (India)

^c AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

Albumin; In vitro release; Lung targeting; Microspheres; Ofloxacin

Indexed keywords

ALBUMIN; MICROSPHERE; OFLOXACIN; OIL; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RELEASE; DRUG SAFETY; DRUG STABILITY; DRUG TARGETING; DRUG TISSUE LEVEL; DRUG TRANSPORT; EMULSION; FEMALE; HISTOPATHOLOGY; LUNG; LUNG PARENCHYMA; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEMALE; LUNG; MALE; MICE; MICE, INBRED STRAINS; MICROSPHERES; OFLOXACIN; PARTICLE SIZE; TISSUE DISTRIBUTION;

EID: 69649084169     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.07.020     Document Type: Article

References (22)

1. Canan H., Nursin G., and Nevin E. Mucoadhesive microspheres containing gentamicin sulphate for nasal administration: preparation and in vitro characterization. Farmaco 58 (2003) 11-16
2. Delgado A., Sorianoil S.E., and Oliva M.E. Radiolabelled biodegradable microspheres for lung imaging. Eur. J. Pharm. Biopharm. 50 (2000) 227-236
3. Dhanaraj S.A., Gowthamarajan K., Shanthi K., and Suresh B. Albumin microsphere containing methotreate; a lung specific delivery system. Ind. J. Pharm. Sci. 63 (2001) 196-199
4. Gupta P.K., and Hung C.T. Quantitative evaluation of targeted drug delivery system. Int. J. Pharm. 56 (1989) 217-226
5. Hai H.P., Ping L., Francois G., and Alekha. Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery systems by precipitation and spray drying technique. AAPS PharmSci Tech 3 (2002) (Article 1)
6. Himangshu B., Dulal C.R., Rohini K.R., and Hirendra N.K. Pharmacokinetics, tissue residue and plasma protein binding of ofloxacin in goats. J. Vet. Sci. 5 (2004) 97-101
7. Huo D., Deng S., Li L., and Ji J. Studies on the poly (lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. Int. J. Pharm. 289 (2005) 63-67
8. Illum L., Davis S.S., Wilson C.G., Thomas N.W., Frier M., and Hardy J.G. Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape. Int. J. Pharm. 12 (1982) 135-146
9. Jia K.L., Nuo W., and Xue S.W. A novel biodegradable system based on gelatin nanoparticles and poly (lactic-co-glycolic acid) microspheres for protein and peptide drug delivery. J. Pharm. Sci. 86 (1997) 891-895
10. In: Jorg K. (Ed). Colloidal Drug Delivery Systems (1994), Publishers Marcel Dekker Inc., New York, USA 219-220
11. 141Ce-labeled microspheres from blood and distribution in specific organs following intravenous and intra arterial administration in beagle dogs. J. Pharm. Sci. 67 (1980) 755-765
12. Lacoulonche F., Gamisans F., Chauvet P., Garica M.L., Espina M., and Egea M.A. Stability and invitro drug release of flurbiprofen-loaded poly-e-carprolactone nanospheres. Drug Dev. Ind. Pharm. 25 9 (1999) 983-993
13. Lu B., Zhang J.Q., and Yang H. Lung-targeting microspheres of carboplatin. Int. J. Pharm. 265 (2003) 1-11
14. Masakazu H., Koichi S., Norihide N., and Hiroyuki N. Simultaneous determination of benofloxacin, danofloxacin and ofloxacin in chicken tissue by high-performance liquid chromatography. J. Chromatogr. 653 (1994) 69-76
15. Nanji A.A., Jakelainen K., Fotouhinia M., Rahemtulla A., Thomas P., Tipoe L.G., Grace L.S.U., and Dannenberg A.J. Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin and chemokines. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2002) 348-356
16. Pandey S., Manjumder M., Singh U.V., and Udupa N. Biodegradable microspheres of gentamicin sulphate. Ind. J. Pharm. Sci. 64 (2002) 81-85
17. Shixuan Z., Xiujuan G., Kaihua S., Puwen Y., and Xiulan J. Evaluation of poly (d,l-lactide-co-glycolide) microspheres for the lung-targeting of yuanhuacine, a novel DNA topoisomerase I inhibitor. J. Drug Target. 17 4 (2009) 286-293 1029-2330
18. Sree H., and Shobha R. Drug targeting to lungs by way of microspheres. Arch. Pharm. Res. 29 7 (2006) 598-604
19. Svein K., Knut D., Tove J., Odd A.A., and Tore O. Optimization of a production process from the in vivo response of a diagnostical drug. Comput. Chem. Eng. 21 (1997) S343-S348
20. Tadashi O., and Kazunobu S.M. Determination of ofloxacin in human serum by high performance liquid chromatography with column swithing. J. Chromatogr. 573 (1992) 289-293
21. Yuk J.H., Nightingale C.H., Quintiliani R., and Sweeney K.R. Bio-availability and pharmacokinetics of ofloxacin in healthy volunteers. Antimicrob. Agents Chemother. 35 (1991) 384-386
22. Zhang X.L., Reng J.P., and Zhang D.P. Pharmacokinetic study and comparison of carboplatin and cisplatin native to china in rabbits. Chin. J. Hosp. Pharm. 12 (1992) 387-389